biosafety level
METPO:1001101 · CLASS · REVIEWED
A quality that categorizes biological agents according to their hazard level and required containment measures.
Biosafety-level hazard-classification axis
Edge evidence
-
pathogen hazard properties
causes
biosafety level
biolink:causesPathogen transmissibility, severity, and treatability jointly determine biosafety-level classification.
-
DOI:10.1146/annurev.micro.62.081307.162938virulence factors
-
-
biosafety level
mandates
containment requirements
Each biosafety level mandates specific containment practices and engineering controls.
-
DOI:10.1146/annurev.micro.62.081307.162938pathogenesis
-
-
biosafety level 1
is a
biosafety level
rdfs:subClassOfBSL-1 is a biosafety-level classification.
-
DOI:10.1146/annurev.micro.62.081307.162938host
-
-
biosafety level 2
is a
biosafety level
rdfs:subClassOfBSL-2 is a biosafety-level classification.
-
DOI:10.1146/annurev.micro.62.081307.162938infection
-
-
biosafety level 3
is a
biosafety level
rdfs:subClassOfBSL-3 is a biosafety-level classification.
-
DOI:10.1146/annurev.micro.62.081307.162938pathogen
-
-
biosafety level 4
is a
biosafety level
rdfs:subClassOfBSL-4 is a biosafety-level classification.
-
DOI:10.1146/annurev.micro.62.081307.162938toxins
-
-
biosafety level 5
is a
biosafety level
rdfs:subClassOfBSL-5 is a proposed biosafety-level classification beyond BSL-4.
-
DOI:10.1146/annurev.micro.62.081307.162938host cells
-
-
hazard identification and risk assessment
guides selection of
containment requirements
Hazard identification and risk assessment guide selection of containment/control measures.
-
DOI:10.1016/j.jobb.2021.09.002
-
-
risk group classification (RG1-RG4)
informs
biosafety level
Risk group classification (RG1-RG4) maps to / informs the biosafety containment level.
-
DOI:10.3390/laboratories1030013
-
-
aerosol/inhalation transmission route
increases requirement for
BSL-3 containment requirement
Inhalation/aerosol transmissibility increases the requirement for BSL-3 containment.
-
DOI:10.3390/laboratories1030013
-
-
lack of effective treatment or vaccine
supports classification at
BSL-4 containment requirement
Absence of effective treatment or vaccine supports classification at BSL-4.
-
DOI:10.3390/laboratories1030013
-
-
aerosol/inhalation transmission route
is input to
hazard identification and risk assessment
Route of inoculation / modes of transmission is a practical input to biorisk assessment.
-
DOI:10.1089/apb.2022.0040
-
-
infectious dose
is input to
hazard identification and risk assessment
Infectious dose is a practical criterion used in biosafety risk assessment.
-
DOI:10.1089/apb.2022.0040
-
Provenance
- Source
- METPO (2025-11-25)
- Definition source
- DOI:10.1146/annurev.micro.62.081307.162938
Parent traits (1)
Children (5)
Synonyms (1)
- Safety information.risk assessment.biosafety level
kg-microbe context
Matched 1 kg-microbe node via direct_metpo.
METPO:1001101[-2.107, -3.186, -2.412, +0.971, …]
Nearest neighbors in embedding space
- ecology biosafety level 5 0.961
- ecology biosafety level 4 0.951
- upper quality 0.905
- genomics mobile genetic element 0.905
- genomics genomic island 0.905
- genomics genome streamlining 0.905
- genomics ploidy 0.905
- genomics genome size 0.905
Deep research
# Curation Report: Biosafety Level (METPO:1001101) ## Executive summary **Recommended interpretation.** “Biosafety level” is best represented as an **assigned containment class for a defined activity**, not as an intrinsic microbial phenotype. The assignment integrates (i) agent hazard—pathogenicity, infectivity, transmission, host range, disease severity, and availability of prevention or treatment—with (ii) the proposed manipulation and (iii) available risk controls. Risk group is therefore an input to, but not a synonym for, biosafety level. Published descriptions place BSL-1 through BSL-4 on an ascending containment scale: BSL-1 covers agents not known to cause disease in healthy adults; BSL-2 moderate hazards; BSL-3 agents capable of serious or potentially lethal aerosol/respiratory infection; and BSL-4 agents posing high aerosol-transmission risk for which effective vaccines or therapies may be unavailable. (kaufer2020laboratorybiosafetymeasures pages 3-4, kaufer2020laboratorybiosafetymeasures pages 4-5) For TraitMech, the most defensible model is a **hazard-to-containment decision graph** rather than a conventional gene-to-phenotype graph: `microbial mechanisms → infection/transmission/treatment phenotypes → agent hazard assessment + activity exposure assessment → required containment → assigned biosafety level`. The graph should retain separate branches for **intrinsic agent properties**, **activity-specific exposure**, and **risk-mitigation controls**. It should not assert that a particular gene automatically causes a numerical BSL. ## 1. Trait scope and boundaries ### 1.1 In scope The target denotes a quality categorizing biological-agent work according to hazard and required containment. Curatable inputs include: 1. **Agent hazard:** pathogenicity/virulence, infectivity, transmission route and ease, host range, disease severity, environmental persistence, and availability of prophylaxis or treatment. 2. **Activity exposure:** culture propagation, concentration or volume, inoculation route, aerosol-generating manipulation, animal work, and handling of clinical material. 3. **Controls:** primary containment, facility engineering, PPE, validated inactivation/decontamination, occupational-health measures, and—where engineered organisms are concerned—genetic biocontainment. 4. **Decision outputs:** residual risk, required containment, and assigned BSL. The 2023 WHO–WOAH–Chatham House Biosafety Research Roadmap organized its evidence review around transmission route, infectious dose, laboratory-acquired infection, containment release, and disinfection, supporting these as decision-relevant dimensions. It also concluded that substantial evidence gaps remain and that some practices reflect convention rather than strong empirical support. (blacksell2023thebiosafetyresearch pages 1-2, blacksell2023thebiosafetyresearch pages 2-4) ### 1.2 Nearby concepts that must remain distinct - **Risk group:** agent-centered hazard classification. It informs, but does not uniquely determine, the containment needed for a specific procedure. (kaufer2020laboratorybiosafetymeasures pages 3-4) - **Biosafety level:** the practices, equipment, and facility safeguards selected for an activity. It is contextual rather than a stable genome-encoded phenotype. (kaufer2020laboratorybiosafetymeasures pages 4-5) - **Physical containment level:** jurisdiction-specific facility designation corresponding approximately—but not necessarily identically—to BSL. - **Pathogenicity:** capacity to cause disease; one biological input to hazard classification. - **Virulence:** degree or mechanisms of damage among pathogenic organisms; not equivalent to BSL. - **Biosecurity:** prevention of loss, theft, misuse, diversion, or unauthorized access, whereas biosafety emphasizes accidental exposure and release. The two overlap in biorisk management but should remain separate graph outputs. (pavone2024biologicalcontainmentfor pages 1-2) - **Select-agent/high-consequence status:** a legal or policy designation, not a mechanistic microbial trait. - **Genetic biocontainment:** an engineered control that can reduce persistence or spread; it does not by itself establish a lower BSL. ### 1.3 Boundary cases - **Diagnostic material versus propagated culture:** a clinical specimen may be handled using lower or different controls than high-titer propagation of the same agent after local risk assessment. - **Attenuated, vaccine, or laboratory strains:** parent-species classification should not be transferred automatically; attenuation stability and reversion require evidence. - **Opportunists:** hazard varies with host immune status and exposure route. A species-level assertion may conceal major strain and host-context differences. - **Engineered strains:** inserted virulence, host-range, resistance, or environmental-fitness functions may raise hazard; validated auxotrophy or kill switches may reduce release consequences but require context-specific testing. - **Plant and animal pathogens:** low direct human pathogenicity does not imply low environmental or economic consequence. ASF laboratory containment illustrates the need to assess release risk to animals and the environment, not only worker disease. (pavone2024biologicalcontainmentfor pages 1-2) ## 2. Candidate nodes grouped by type Identifiers below are conservative. Labels are preferable where a precise stable CURIE was not verified. ### A. Trait and decision nodes - **biosafety level** — `METPO:1001101` - risk group — label-only candidate - agent hazard assessment — label-only candidate - activity-specific risk assessment — label-only candidate - exposure likelihood — label-only candidate - consequence severity — label-only candidate - residual biorisk — label-only candidate - required containment — label-only candidate - biosafety / biocontainment — label-only candidate - biosecurity — label-only candidate; keep outside the central phenotype path
Discussions and Knowledge Gaps
This record's graph enumerates bsl1 through bsl5, but BSL-5 is not an assigned containment level in any current national framework -- it appears in proposals for hypothetical agents beyond BSL-4. Is the bsl5 node a real classification this record should carry, or a seeded artefact to retract?
A containment level that does not exist in regulation is not a value the trait can take, and anything downstream that enumerates levels from this graph -- a risk-assessment form, an ontology mapping, a facility-capability query -- would inherit a level with no requirements attached to it. Note what the resolution is NOT: the node is already labelled a proposal and grounded to METPO:1001106, which the corpus carries as its own seeded record at ecology/biosafety_level_5.yaml, so deleting it here would desynchronise this graph from an upstream-seeded record rather than fix anything. A METPO class is not a citable proposal, so the question stands -- but it is answered by finding the source behind METPO:1001106, and any retraction belongs upstream in METPO, not in this graph.
Proposed experiments
- Regulatory provenance check for the BSL-5 designation documentary review of containment frameworks
Provenance
Curation history
-
·
SEEDED_FROM_METPO · seed_from_metpo
imported from data/raw/metpo.owl (CLASS)
-
·
CURATED_CAUSAL_GRAPH · claude
Added DOI-backed causal graph framing biosafety level as a hazard-classification axis driven by pathogen virulence properties, with is-a edges to the five BSL child classifications.
-
·
GROUND_CAUSAL_PREDICATES · claude
Grounded 5 causal-edge predicate_id field(s) via mappings/predicate_grounding.tsv (rdfs:subClassOf×5).
-
·
RENAME_PREDICATE_LABELS · claude
Renamed 1 causal-edge predicate label(s) to align with existing groundings: determines → causes ×1.
-
·
GROUND_CAUSAL_PREDICATES · claude
Grounded 1 causal-edge predicate_id field(s) via mappings/predicate_grounding.tsv (biolink:causes×1).
-
·
ENRICH_CAUSAL_GRAPH · claude
Added 6 evidence-backed generic edges (7 new nodes) from the deep-research report.
-
·
CURATE_KNOWLEDGE_GAPS · claude
Replaced the scan's off-topic scraped sentence with a research question authored from this record's causal graph, anchored it via attaches_to, and sketched an experiment with a decision criterion. The scan's sentence and PMIDs are preserved in the discussion's notes.